Could This Move by Johnson & Johnson Equal Billions for Moderna?

Could This Move by Johnson & Johnson Equal Billions for Moderna?

Submitted by admin on April 2, 2023 - 4:19pm
Source: 
Motley Fool
News Tags: 
JNJ
Moderna Therapeutics
Pfizer
GSK
RSV
vaccines
Headline: 
Could This Move by Johnson & Johnson Equal Billions for Moderna?
snippet: 
  • J&J is dropping out of the adult RSV vaccine race.
  • This leaves the market to Moderna, Pfizer, and GSK; all three are close to reaching commercialization with their vaccine candidates.

Do Not Allow Advertisers to Use My Personal information